ACS Publications. Most Trusted. Most Cited. Most Read
SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection
My Activity

Figure 1Loading Img
  • Open Access
Viewpoint

SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection
Click to copy article linkArticle link copied!

  • Rafal Butowt*
    Rafal Butowt
    L. Rydygier Collegium Medicum, Nicolaus Copernicus University, Ul. CurieSklodowskiej 9, 85-94 Bydgoszcz, Poland
    *Address: Department of Molecular Cell Genetics, L. Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Torun, 85-094 Bydgoszcz, Poland. Email: [email protected]. Phone 0048-52-5853491.
    More by Rafal Butowt
  • Katarzyna Bilinska
    Katarzyna Bilinska
    L. Rydygier Collegium Medicum, Nicolaus Copernicus University, Ul. CurieSklodowskiej 9, 85-94 Bydgoszcz, Poland
Open PDF

ACS Chemical Neuroscience

Cite this: ACS Chem. Neurosci. 2020, 11, 9, 1200–1203
Click to copy citationCitation copied!
https://doi.org/10.1021/acschemneuro.0c00172
Published April 13, 2020
Copyright © 2020 American Chemical Society

Abstract

Click to copy section linkSection link copied!

The novel SARS-CoV-2 virus has very high infectivity, which allows it to spread rapidly around the world. Attempts at slowing the pandemic at this stage depend on the number and quality of diagnostic tests performed. We propose that the olfactory epithelium from the nasal cavity may be a more appropriate tissue for detection of SARS-CoV-2 virus at the earliest stages, prior to onset of symptoms or even in asymptomatic people, as compared to commonly used sputum or nasopharyngeal swabs. Here we emphasize that the nasal cavity olfactory epithelium is the likely site of enhanced binding of SARS-CoV-2. Multiple non-neuronal cell types present in the olfactory epithelium express two host receptors, ACE2 and TMPRSS2 proteases, that facilitate SARS-CoV-2 binding, replication, and accumulation. This may be the underlying mechanism for the recently reported cases of smell dysfunction in patients with COVID-19. Moreover, the possibility of subsequent brain infection should be considered which begins in olfactory neurons. In addition, we discuss the possibility that olfactory receptor neurons may initiate rapid immune responses at early stages of the disease. We emphasize the need to undertake research focused on additional aspects of SARS-CoV-2 actions in the nervous system, especially in the olfactory pathway.

Copyright © 2020 American Chemical Society

Note

This article is made available via the ACS COVID-19 subset for unrestricted RESEARCH re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

1. Fast, Sensitive, and Reliable Tests Are Critical to Slow down a Pandemic

Click to copy section linkSection link copied!

An important factor accelerating the spread of COVID-19 is the high infectivity of this virus. It is related to extraordinarily ability of spike glycoprotein to bind to host receptor with much higher affinity as compared to related SARS-CoV virus. Lower thermostability of SARS-CoV-2 spike protein has also been suggested as a factor contributing to its high infectivity. (1) Although SARS-CoV-2 testing is currently very efficient, public health care systems do not have the capacity to test all the citizens. Thus, the identification of infected but asymptomatic people should be one of the priorities and this should be done as early as possible. Currently, assays that are based on real-time RT-PCR technique are recommended for early detection of the virus. Theoretically, procedures based on RT-PCR are able to detect even a small number of viral RNA particles in biological samples. However, in practice, due to several technical factors, there must be much more viral load in the biological material collected to achieve a reliable diagnosis. Typically nasal and pharyngeal swabs as well as sputum are used as the starting biological material for SARS-CoV-2 testing. It is assumed that this strategy is very efficient in diagnosing infected individuals 5–7 days after onset of symptoms. Unfortunately, it is less efficient in detecting SARS-CoV-2 within 1–4 days after symptoms and in asymptomatic individuals. Therefore, other types of biological samples should be identified to detect SARS-CoV-2 more efficiently about the time of infection.

2. SARS-CoV-2 Affinity to the Respiratory Epithelium in the Nasal Cavity Is Likely Moderate

Click to copy section linkSection link copied!

Because the nasal cavity is the main gate for SARS-CoV-2 entrance, epithelial cells located within this area can be considered as appropriate clinical sample for early virus detection. The nasal cavity contains three main types of mucosa: squamous, respiratory, and olfactory epithelium (Figure 1). Importantly, all these cells are easily accessible for collection by medical staff. According to some gene expression data deposited in databases such as GEO and MGI, respiratory epithelial cells (RECs) express both of the SARS-CoV-2 human proteins required for host cell entry, namely, ACE2 and TRMPSS2 transmembrane proteases (1,2) (Table 1). On the other hand, recent single cell RNaseq studies in humans showed only TMPRSS2 expression in RECs without detecting ACE2. (3) Other RNaseq studies showed rather low levels of ACE2 in RECs. (4) However, according to the mouse atlas, in embryonic RECs, ACE2 expression was clearly shown by in situ hybridization but TMPRSS2 expression was not examined by this approach. Taken together, current data suggest that RECs present in the nasal cavity express rather low levels of ACE2 and TMPRSS2 proteins as compared to epithelial cells located at lower parts of the human respiratory pathway. However, it should be emphasized that the expression data in RECs are clearly incomplete and require further detailed examination. Before drawing a final conclusions about SARS-CoV-2 affinity to these cells, different aspects such as age-dependence and possible effects of pathological conditions on ACE2/TMPRSS2 expression should also be addressed, preferably at cell-type resolution.

Figure 1

Figure 1. Diagram of human nasal cavity with respiratory and olfactory epithelium areas indicated in blue and yellow, respectively.

Table 1. ACE2 and TMPRSS2 Expression in Human and Mouse Nasal Cavity Epitheliaa
nasal cavityhACE2hTMPRSS2mACE2mTMPRSS2database
respiratory epithelium+++NDBgee, GEO
olfactory epithelium+ND++Bgee, GEO
olfactory receptor neuronsNDND− or low+Bgee, GEO
a

Data based on Affymetrix and RNAseq. hACE2, human ACE2; hTMPRSS2, human TMPRSS2; mACE2, mouse ACE2; mTMPRSS2, mouse TMPRSS2. +, positive expression; ND, no data available. Note that olfactory receptor neurons are major part of OE; however, OE also contains several types of non-neuronal cells.

3. The Olfactory Epithelium As a Site of SARS-CoV-2 Replication, Accumulation, and Brain Entrance

Click to copy section linkSection link copied!

Another suitable source of biological samples for early SARS-CoV-2 detection is the olfactory epithelium (OE), which is easily accessible within the nasal cavity (Figure 1). Recent reports indicate that total anosmia or partial loss of the sense of smell are early markers of SARS-CoV-2 infection. This phenomenon may be caused by different and yet unidentified factors, e.g., “cytokine storm” initiated in some patients or direct damage of the olfactory receptor neurons (ORNs) located in the olfactory epithelium (Figure 2). The latter possibility is particularly likely due to the fact that cells located in the OE express both protein receptors required for effiecient SARS-CoV-2 infection in humans. Several data sets deposited in gene expression databases show relatively high expression levels of ACE2 and TMPRSS2 in human and murine olfactory mucosa (Table 1). In mammals, OE is a continuously regenerating multilayer structure containing both neuronal and non-neuronal cells (Figure 2). The key question is whether ACE2 and TRMPSS2 expression in the OE is neuronal or non-neuronal or whether it occurs in both cell types. Neuronal expression of host receptors will likely facilitate SARS-CoV-2 brain infection through the uptake into ciliated dendrites/soma and subsequent anterograde axonal transport along the olfactory nerve. Non-neuronal expression of ACE2/TRMPSS2 may possibly establish nasal cavity OE as a virus reservoir. Three major RNaseq transcriptome studies conducted in human and murine OE consistently suggest non-neuronal expression of ACE2. (4−6) Hence, ACE2 expression is not clearly detected in mature ORNs, which are the only OE neurons connected to the brain. Expression of TMPRS2 seems to be higher compared to that of ACE2 and takes place likely in both neuronal and non-neuronal OE cells. (5,6) One state-of-the-art RNaseq study showed intriguingly mosaic TMPRSS2 expression which occurs only in subpopulation of mature ORNs, even though the majority of other genes were more evenly expressed in these neurons. (6) It suggests that some olfactory neurons in the OE may be more vulnerable for viral infection than other morphologically similar ORNs. Moreover, expression of murine ACE2 and TMPRSS2 evaluated by microarrays has a tendency to increase with age (Table 2). If it is true in humans, then in elderly people the OE may be more sensitive to SARS-CoV-2 accumulation. However, it should be remembered that although ACE2 is a mandatory factor for viral entry into the cell, TMPRSS2 can probably be replaced by other proteases from this family such as TMPRSS4, TMPRSS11A, 11D, and 11E1. Of these proteases, only TMPRSS4 is also present in the OE, likely in immature neurons and in non-neuronal cells. (5,6)

Figure 2

Figure 2. Basic organization of the olfactory epithelium (OE). Olfactory neurons continuously regenerate through human life and therefore are at different stages of differentiation. Some non-neuronal cells are shown, e.g., progenitors, sustentacular cells, and olfactory ensheathing cells.

Table 2. ACE2 and TMPRSS2 Expression Scores in Mouse Olfactory Epithelium According to the Bgee Databasea
age of miceACE2TMPRSS2
6 weeks old49.478.7
6 months old61.489.5
a

www.bgee.org, Affymetrix microarrays, score range 0–10).

It is known from a previous SARS-CoV pandemic that, that even though lungs were the major site of infection, the brain was also involved in some patients. In addition, it was shown in transgenic mice expressing human ACE2 that SARS-CoV infected the brain through ORNs. (7) Genetically modified mice express only human ACE2 and not human TMPRSS2. This may additionally suggest that murine ORNs express endogenous TMPRSS2, because both proteins are required for efficient infection. Intriguingly, there was an approximately 60 h delay from the time of nasal infection until SAR-CoV virus detection in the olfactory bulb. During that time the virus likely replicated and accumulated in different OE cells, because its subsequent transport to further parts of the brain required a relatively short time of an additional 12–20 h. (7) The results from transgenic hACE2 mice indicate that SARS-CoV probably uses transneuronal/transsynaptic routes employing axonal transport in the brain and this can also be true for SARS-CoV-2. It is known for other viruses, e.g., rabies virus, that they can hijack existing vesicular axonal transport machineries to spread within the brain. There is very recent evidence that SARS-CoV-2 enters early and late endosomal compartments in non-neuronal cells; thus, it may possibly be directed to the vesicular axonal pathway in neurons. (1) However, it should be remembered that the hACE2 mouse is an overexpressor model with expression of human ACE2 controlled by human keratin K18 promoter. For this reason, alternative and more physiological knock-in models for SARS-CoV-2 studies in the nervous system would be desirable. Alternatively to the olfactory axonal route, SARS-CoV-2 may pass from non-neuronal OE cells directly to cerebrospinal fluid surrounding olfactory nerve bundles, located near the cribriform plate. Once in cerebrospinal fluid, the virus could reach most of the brain areas including medulla oblongata where cardiorespiratory controlling nuclei are located. (8)
Brain infection in COVID-19 patients is currently being seriously considered because of many reports of neurological impairments such as stroke, epilepsy ,and encephalitis. The ACE2 expression in glia and in neurons in the brain is low but also well documented. But the specific sites where SARS-CoV-2 enters the brain are not clearly identified. (8) Mature olfactory neurons present in the OE are probably one such place. However, SARS-CoV-2 virus must first invade high ACE2-expressing yet unidentified non-neuronal OE cells and then pass to low-ACE2-expressing mature ORNs to be finally transported along olfactory axons to the brain. A good candidate for such cells is specialized glia known as olfactory ensheathing cells (OECs). OECs were previously shown to enhance human herpesvirus-6 replication and accumulation in the OE before virus infected the brain. (9) Many studies have already shown that this type of glia cells can supply axons with macromolecules by way of exosomes and this could be a mechanism of ACE2-independent virus transfer from OEC to ORN axons.

4. Olfactory Neurons in OE May Mediate Antiviral Responses

Click to copy section linkSection link copied!

It is known that the nervous system can shape responses of the innate immunity system. ORNs which are located with direct contact with the external environment are ideally suited for that role. Recetly it was shown in fish that ORNs initiate ultrarapid immune responses after binding rhabdovirus surface glycoprotein. (10) The virus binding results in neuronal activation and proinflammatory effects in OE but inhibits inflammation in the brain. As a consequence, some neurons undergo apoptosis, which may inhibit the reception of olfactory stimuli for some time. This data reveals the possible universal role of ORNs as first line viral sensors and initiators of antiviral protective immune responses. Based on the above conclusion, there is an exciting possibility that SARS-CoV-2 binding to ORNs initiates that kind of rapid immune response. Induction of the innate immune system through ORNs does not necessarily have to be mediated by ACE2 and TMPRSS2, but it may require additional yet unidentified host protein(s) with the ability to transmit intracellular signaling. From this point of view, infected people who show signs of olfactory dysfunctions may actually represents those individuals with faster and/or stronger immune response and better body mobilization against the SARS-CoV-2 infection. Therefore, it will be interesting to examine groups of patients with and without olfactory dysfunction and correlate it with the severity of their symptoms and percentage of recovery. Intriguingly, older patients which are known to be much more sensitive to SARS-CoV-2 infection are also those who have their sense of smell compromised simply because of their age. Reduced numbers of ORNs in older people can potentially slow down their early immune response and, consequently, lead to more severe COVID-19 symptoms.

5. Conclusions and Future Directions

Click to copy section linkSection link copied!

There are many reasons to urgently start thorough studies on the role of the OE in SARS-CoV-2 binding, accumulation, and brain infection and of participating in the early response of the immune system. Primarily, the OE may possibly serve as a tissue source for early virus detection to minimize false-negative test results. Analyzing viral loads in OE may also improve virus detection in asymptomatic individuals. Second, it should be noted that brain infection may cause delayed and long-lasting neurological impairment even in patients who no longer show respiratory symptoms and are currently considered recovered. Therefore, there is a need to establish which cell types in the OE bind and accumulate virus particles and whether the virus is transferred between OE cells. The large-scale transcriptomic data are only an approximation, and they lack the necessary resolution which can only be achieved by in vivo studies focused on single proteins. The transgenic hACE2 mouse together with epidemiologic COVID-19 data suggest a very dangerous phenomenon that hypothetical coronavirus with more neurotropic properties could be much more deadly to humans. By examining complex interactions of SARS-CoV-2 with the cells present within the OE, we could be better prepared for that type of virus. Future studies should also investigate how age-related differences affect SARS-CoV-2 actions in the OE. Finally, the scenario that the OE/ORN is involved in mediating the rapid response of the immune system is well worth investigating and must be experimentally verified. Epidemiological data should be collected to search for potential correlation between olfactory dysfunction and COVID-19 symptoms as well as severity.

Author Information

Click to copy section linkSection link copied!

  • Corresponding Author
    • Rafal Butowt - L. Rydygier Collegium Medicum, Nicolaus Copernicus University, Ul. CurieSklodowskiej 9, 85-94 Bydgoszcz, Poland Email: [email protected]
  • Author
    • Katarzyna Bilinska - L. Rydygier Collegium Medicum, Nicolaus Copernicus University, Ul. CurieSklodowskiej 9, 85-94 Bydgoszcz, Poland
  • Funding

    This publication has been supported by a grant of Polish National Science Centre (UMO-2013/09/B/NZ3/02359).

  • Notes
    The authors declare no competing financial interest.

Acknowledgments

Click to copy section linkSection link copied!

The authors would like to thank Christopher von Bartheld (University of Nevada, Reno) and Michal Szpinda (Nicolaus Copernicus University) for their valuable and criitical comments.

References

Click to copy section linkSection link copied!

This article references 10 other publications.

  1. 1
    Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., and Ren, L. (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 11, 1620,  DOI: 10.1038/s41467-020-15562-9
  2. 2
    Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kruger, N., Herrler, T., Erichsen, S., Schiergens, E. S., Herrler, G., Wu, N.-H., Nitsche, A., Muller, M. A., Drosten, C., and Pohlmann, S. (2020) SARS-CoV-2 cell entry depends on ACE2 and TRMPSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 110,  DOI: 10.1016/j.cell.2020.02.052
  3. 3
    Ruiz Garcia, S., Deprez, M., Lebrigand, K., Cavard, A., Paquet, A., Arguel, M.-J., and Zaragosi, L.-E. (2019) Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development 146, dev.177428,  DOI: 10.1242/dev.177428
  4. 4
    Olender, T., Keydar, I., Pinto, J. M., Tatarskyy, P., Alkelai, A., Chien, M.-S., Fishilevich, S., Restrepo, D., Matsunami, H., Gilad, Y., and Lancet, D. (2016) The human olfactory transcriptome. BMC Genomics 17, 619,  DOI: 10.1186/s12864-016-2960-3
  5. 5
    Kangeswaran, N., Demond, M., and Nagel, M. (2015) Deep sequencing of the murine olfactory receptor transcriptome. PLoS One 10 (1), e0113170,  DOI: 10.1371/journal.pone.0113170
  6. 6
    Saraiva, L. R., Ibarra-Soria, X., Khan, M., Omura, M., Scialdone, A., Mombaerts, P., Marioni, J. C., and Logan, D. W. (2015) Hierarchical deconstruction of mouse olfactory sensory neurons: from whole mucosa to single-cell RNA-seq. Sci. Rep. 5, 18178,  DOI: 10.1038/srep18178
  7. 7
    Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., and Perlman, S. (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol 82 (5), 726475,  DOI: 10.1128/JVI.00737-08
  8. 8
    Harberts, E., Yao, K., Wohler, J. E., Maric, D., Ohayon, J., Henkin, R., and Jacobson, S. (2011) Human herpesvirus-6 entry into CNS through the olfactory pathway. Proc. Natl. Acad. Sci. U. S. A. 108 (33), 13734,  DOI: 10.1073/pnas.1105143108
  9. 9
    Baig, A. M., Khaleeq, A., Ali, U., and Syeda, H. (2020) Evidence of the COVID-19 virus targeting the CNS: host-virus interactions and proposed neurotropic mechanisms. ACS Chem. Neurosci. 11, 995,  DOI: 10.1021/acschemneuro.0c00122
  10. 10
    Sepahi, A., Kraus, A., Casadei, E., Johnston, C. A., Galindo-Villegas, J., Kelly, C., Garcia-Moreno, D., Munoz, P., Mulero, V., Huertas, M., and Salinas, I. (2019) Olfactory sensory neurons mediate ultrarapid antiviral immune responses in a TrkA-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 116 (25), 1242836,  DOI: 10.1073/pnas.1900083116

Cited By

Click to copy section linkSection link copied!
Citation Statements
Explore this article's citation statements on scite.ai

This article is cited by 247 publications.

  1. Qingyu Zhan, Kristina M. Babler, Mark E. Sharkey, Ayaaz Amirali, Cynthia C. Beaver, Melinda M. Boone, Samuel Comerford, Daniel Cooper, Elena M. Cortizas, Benjamin B. Currall, Jonathan Foox, George S. Grills, Erin Kobetz, Naresh Kumar, Jennifer Laine, Walter E. Lamar, Alejandro M.A. Mantero, Christopher E. Mason, Brian D. Reding, Maria Robertson, Matthew A. Roca, Krista Ryon, Stephan C. Schürer, Bhavarth S. Shukla, Natasha Schaefer Solle, Mario Stevenson, John J. Tallon Jr, Collette Thomas, Tori Thomas, Dušica Vidović, Sion L. Williams, Xue Yin, Helena M. Solo-Gabriele. Relationships between SARS-CoV-2 in Wastewater and COVID-19 Clinical Cases and Hospitalizations, with and without Normalization against Indicators of Human Waste. ACS ES&T Water 2022, 2 (11) , 1992-2003. https://doi.org/10.1021/acsestwater.2c00045
  2. Samir F. El-Mashtoly, Klaus Gerwert. Diagnostics and Therapy Assessment Using Label-Free Raman Imaging. Analytical Chemistry 2022, 94 (1) , 120-142. https://doi.org/10.1021/acs.analchem.1c04483
  3. Raziyeh Najafloo, Jila Majidi, Alimohamad Asghari, Mina Aleemardani, Seyed Kamran Kamrava, Sara Simorgh, Amelia Seifalian, Zohreh Bagher, Alexander M. Seifalian. Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments. ACS Chemical Neuroscience 2021, 12 (20) , 3795-3805. https://doi.org/10.1021/acschemneuro.1c00477
  4. Shalu Yadav, Mohd. Abubakar Sadique, Pushpesh Ranjan, Neeraj Kumar, Ayushi Singhal, Avanish K. Srivastava, Raju Khan. SERS Based Lateral Flow Immunoassay for Point-of-Care Detection of SARS-CoV-2 in Clinical Samples. ACS Applied Bio Materials 2021, 4 (4) , 2974-2995. https://doi.org/10.1021/acsabm.1c00102
  5. Sheila Veronese, Andrea Sbarbati. Chemosensory Systems in COVID-19: Evolution of Scientific Research. ACS Chemical Neuroscience 2021, 12 (5) , 813-824. https://doi.org/10.1021/acschemneuro.0c00788
  6. Francisco J. Barrantes. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses. ACS Chemical Neuroscience 2020, 11 (18) , 2793-2803. https://doi.org/10.1021/acschemneuro.0c00434
  7. Katarzyna Bilinska, Rafal Butowt. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism. ACS Chemical Neuroscience 2020, 11 (15) , 2152-2155. https://doi.org/10.1021/acschemneuro.0c00406
  8. Ibrahim Sayin, Zahide Mine Yazici. Taste and Smell Impairment in SARS-CoV-2 Recovers Early and Spontaneously: Experimental Data Strongly Linked to Clinical Data. ACS Chemical Neuroscience 2020, 11 (14) , 2031-2033. https://doi.org/10.1021/acschemneuro.0c00296
  9. Abolfazl Torabi, Esmaeil Mohammadbagheri, Nader Akbari Dilmaghani, Amir-Hossein Bayat, Mobina Fathi, Kimia Vakili, Rafieh Alizadeh, Omidvar Rezaeimirghaed, Mohammadreza Hajiesmaeili, Mahtab Ramezani, Leila Simani, Abbas Aliaghaei. Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia. ACS Chemical Neuroscience 2020, 11 (13) , 1909-1913. https://doi.org/10.1021/acschemneuro.0c00249
  10. Katarzyna Bilinska, Patrycja Jakubowska, Christopher S. Von Bartheld, Rafal Butowt. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chemical Neuroscience 2020, 11 (11) , 1555-1562. https://doi.org/10.1021/acschemneuro.0c00210
  11. Sonia Villapol. Neuroinflammation: Unraveling acute and Long COVID symptoms. 2025, 437-457. https://doi.org/10.1016/B978-0-443-19170-1.00017-6
  12. Weronika Daria Krahel, Michalina Bartak, Joanna Cymerys. Acute and long-term SARS-CoV-2 infection and neurodegeneration processes—circulus vitiosus. Acta Virologica 2024, 68 https://doi.org/10.3389/av.2024.12765
  13. Azin Tabari, Fatemeh Farrokh, Mohsen Bakhshi, Azadeh Tabari, Seyed Mousa Sadrehosseini, Babak Saedi, Saeed Farzanehfar, Mehrshad Abbasi. Subjective and objective effects of radioiodine therapy on the sense of smell. European Archives of Oto-Rhino-Laryngology 2024, 281 (10) , 5319-5324. https://doi.org/10.1007/s00405-024-08761-3
  14. Panagiotis Theofilis, Evangelos Oikonomou, Maria Vasileiadou, Dimitris Tousoulis. A Narrative Review on Prolonged Neuropsychiatric Consequences of COVID-19: A Serious Concern. Heart and Mind 2024, 8 (3) , 177-183. https://doi.org/10.4103/hm.HM-D-24-00019
  15. Amr Seifelnasr, Mohamed Talaat, Xiuhua April Si, Jinxiang Xi. Delivery of Agarose-aided Sprays to the Posterior Nose for Mucosa Immunization and Short-term Protection against Infectious Respiratory Diseases. Current Pharmaceutical Biotechnology 2024, 25 (6) , 787-798. https://doi.org/10.2174/1389201024666230801142913
  16. Gauthier Duloquin, Thibaut Pommier, Marjolaine Georges, Maurice Giroud, Charles Guenancia, Yannick Béjot, Gabriel Laurent, Claudio Rabec. Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2. Journal of Clinical Medicine 2024, 13 (5) , 1397. https://doi.org/10.3390/jcm13051397
  17. Ali Azargoonjahromi. Role of the SARS-CoV-2 Virus in Brain Cells. Viral Immunology 2024, 37 (2) , 61-78. https://doi.org/10.1089/vim.2023.0116
  18. Wei Zhang, Aaron J. Gorelik, Qing Wang, Sara A. Norton, Tamara Hershey, Arpana Agrawal, Janine D. Bijsterbosch, Ryan Bogdan. Associations between COVID-19 and putative markers of neuroinflammation: A diffusion basis spectrum imaging study. Brain, Behavior, & Immunity - Health 2024, 36 , 100722. https://doi.org/10.1016/j.bbih.2023.100722
  19. Debashis Dutta, Jianuo Liu, Huangui Xiong. Impact of SARS-CoV-2/COVID-19 on HIV-1-associated neurocognitive disorders. 2024, 355-378. https://doi.org/10.1016/B978-0-323-99744-7.00036-5
  20. Shaojiong Zhou, Tao Wei, Xiaoduo Liu, Yufei Liu, Weiyi Song, Xinwei Que, Yi Xing, Zhibin Wang, Yi Tang. Causal effects of COVID-19 on structural changes in specific brain regions: a Mendelian randomization study. BMC Medicine 2023, 21 (1) https://doi.org/10.1186/s12916-023-02952-1
  21. Bian Hu, Mengdan Gong, Yizhen Xiang, Siyuan Qu, Hai Zhu, Dong Ye. Mechanism and treatment of olfactory dysfunction caused by coronavirus disease 2019. Journal of Translational Medicine 2023, 21 (1) https://doi.org/10.1186/s12967-023-04719-x
  22. Qendresa Hoti, Gokce Akan, Gulten Tuncel, Emine Unal Evren, Hakan Evren, Kaya Suer, Tamer Sanlidag, Mahmut Cerkez Ergoren. Altered expression levels of TAS1R2 and TAS1R3 genes among SARS-CoV-2 variants of concerns. Molecular Biology Reports 2023, 50 (11) , 9343-9351. https://doi.org/10.1007/s11033-023-08893-5
  23. Y.M. Hovhannisyan. ԿՈՎԻԴ-19 ԱՍՈՑԱՑՎԱԾ ԿՈԳՆԻՏԻՎ ԽԱՆԳԱՐՈՒՄՆԵՐԻ ԳՐԱԿԱՆ ԱԿՆԱՐԿ. MEDICINE, SCIENCE AND EDUCATION 2023, (36) , 53-61. https://doi.org/10.56936/18291775-2023.36-53
  24. Ting-Hui Liu, Chung-Han Ho, Daniel Tzu-Li Chen, Jheng-Yan Wu, Po-Yu Huang, Chih-Cheng Lai, Kuang-Yang Hsieh, Kuan-Pin Su. Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients. Brain, Behavior, and Immunity 2023, 114 , 453-461. https://doi.org/10.1016/j.bbi.2023.09.008
  25. Waqas Ahmed, Jia Feng, Yifan Zhang, Lukui Chen. SARS-CoV-2 and Brain Health: New Challenges in the Era of the Pandemic. Microorganisms 2023, 11 (10) , 2511. https://doi.org/10.3390/microorganisms11102511
  26. Allison B. Reiss, Caitriona Greene, Christopher Dayaramani, Steven H. Rauchman, Mark M. Stecker, Joshua De Leon, Aaron Pinkhasov. Long COVID, the Brain, Nerves, and Cognitive Function. Neurology International 2023, 15 (3) , 821-841. https://doi.org/10.3390/neurolint15030052
  27. Ting‐Hui Liu, Jheng‐Yan Wu, Po‐Yu Huang, Ya‐Wen Tsai, Chih‐Cheng Lai. The effect of nirmatrelvir‐ritonavir on the long‐term risk of neuropsychiatric sequelae following COVID‐19. Journal of Medical Virology 2023, 95 (7) https://doi.org/10.1002/jmv.28951
  28. Sarang Mahajan, Deepshikha Sen, Anantu Sunil, Priyadharshini Srikanth, Shruti D. Marathe, Karishma Shaw, Mahesh Sahare, Sanjeev Galande, Nixon M. Abraham. Knockout of angiotensin converting enzyme-2 receptor leads to morphological aberrations in rodent olfactory centers and dysfunctions associated with sense of smell. Frontiers in Neuroscience 2023, 17 https://doi.org/10.3389/fnins.2023.1180868
  29. V. V. Rassokhin, E. I. Svetashova, A. A. Shcherbakov, A. Yu. Polushin, M. A. Kucher, I. V. Kazantsev, O. V. Goloshchapov, R. V. Klementieva, A. A. Sinyaev, V. N. Ovechkina, A. A. Lazarev, M. O. Popova, A. D. Kulagin. Mechanisms of central nervous system damage in COVID-19. HIV Infection and Immunosuppressive Disorders 2023, 15 (1) , 7-22. https://doi.org/10.22328/2077-9828-2023-15-1-7-22
  30. Debashis Dutta, Jianuo Liu, Huangui Xiong. The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications. Viruses 2023, 15 (5) , 1117. https://doi.org/10.3390/v15051117
  31. X Dai, X Cao, Q Jiang, B Wu, T Lou, Y Shao, Y Hu, Q Lan. Neurological complications of COVID-19. QJM: An International Journal of Medicine 2023, 116 (3) , 161-180. https://doi.org/10.1093/qjmed/hcac272
  32. Alan Pui-Lun Tai, Mei-Kei Leung, Benson Wui-Man Lau, Shirley Pui-Ching Ngai, Way Kwok-Wai Lau. Olfactory dysfunction: A plausible source of COVID-19-induced neuropsychiatric symptoms. Frontiers in Neuroscience 2023, 17 https://doi.org/10.3389/fnins.2023.1156914
  33. Diana Cevallos-Macías, Gilberto Vizcaíno Salazar, Aline Siteneski. Neurological manifestations associated with SARS-CoV-2 infection: an updated review.. Investigación Clínica 2023, 64 (1) , 108-122. https://doi.org/10.54817/IC.v64n1a08
  34. Sabereh Ahmadzadeh, , Mehrnoosh Sedighi, , Amin Torkashvand, , Pejman Hashemzadeh, , Fateme Shafiei, , Mohammad Torkashvand, , Atefeh Hasan-Zadeh, . Pathological Effects of COVID-19 on Body Organs. Journal of Medical Microbiology and Infectious Diseases 2023, 11 (1) , 1-19. https://doi.org/10.52547/JoMMID.11.1.1
  35. Anna Campabadal, Javier Oltra, Carme Junqué, Núria Guillen, María Ángeles Botí, Roser Sala‐Llonch, Gemma C. Monté‐Rubio, Gema Lledó, Nuria Bargalló, Lorena Rami, Raquel Sánchez‐Valle, Bàrbara Segura. Structural brain changes in post‐acute COVID‐19 patients with persistent olfactory dysfunction. Annals of Clinical and Translational Neurology 2023, 10 (2) , 195-203. https://doi.org/10.1002/acn3.51710
  36. Ian Z. Ong, Dennis L. Kolson, Matthew K. Schindler. Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC). Biomedicines 2023, 11 (2) , 377. https://doi.org/10.3390/biomedicines11020377
  37. N.Y. Lashch, A.R. Yunyaev, E.D. Evsyukova. The alleged mechanisms of olfactory disorders in the new coronavirus infection. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 2023, 123 (2) , 7. https://doi.org/10.17116/jnevro20231230217
  38. Francisco Alves de Sousa, João Tarrio, André Sousa Machado, Joana Raquel Costa, Catarina Pinto, Ana Nóbrega Pinto, Bruno Moreira, Luís Meireles. Olfactory Cleft Length: A Possible Risk Factor for Persistent Post-COVID-19 Olfactory Dysfunction. ORL 2023, 85 (3) , 119-127. https://doi.org/10.1159/000527141
  39. Haipeng Cui, Wenwei Pan, Tiechuan Li, Xiaotian Shen, Ye Chang, Wei Pang, Xuexin Duan. Rapid purification and enrichment of viral particles using self-propelled micromotors. Nanoscale 2023, 102 https://doi.org/10.1039/D3NR02812G
  40. Chantal A. Pileggi, Gaganvir Parmar, Hussein Elkhatib, Corina M. Stewart, Irina Alecu, Marceline Côté, Steffany A.L. Bennett, Jagdeep K. Sandhu, Miroslava Cuperlovic-Culf, Mary-Ellen Harper. The SARS-CoV-2 spike glycoprotein interacts with MAO-B and impairs mitochondrial energetics. Current Research in Neurobiology 2023, 5 , 100112. https://doi.org/10.1016/j.crneur.2023.100112
  41. Md. Rashidur Rahman, Raushanara Akter, Sharmind Neelotpol, Iffat Islam Mayesha, Afrina Afrose. The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer’s Like Brain Changes on Severely SARS-CoV-2 Infected Patients. American Journal of Alzheimer's Disease & Other Dementias® 2023, 38 https://doi.org/10.1177/15333175231214974
  42. Reiza Dolendo Ventura, Jun-Sang Bae, Eun Hee Kim, Shin Hyuk Yoo, Gwanghui Ryu, Ji-Hun Mo. Evaluation of the effects of photobiomodulation treatment on the neuronal development of olfactory stem cells. Medical Lasers 2022, 11 (4) , 208-218. https://doi.org/10.25289/ML.22.048
  43. Sebastian Meller, Maryam Sultan Ali Al Khatri, Hamad Khatir Alhammadi, Guadalupe Álvarez, Guillaume Alvergnat, Lêucio Câmara Alves, Chris Callewaert, Charles G. B. Caraguel, Paula Carancci, Anne-Lise Chaber, Marios Charalambous, Loïc Desquilbet, Hans Ebbers, Janek Ebbers, Dominique Grandjean, Claire Guest, Hugues Guyot, Anna Hielm-Björkman, Amy Hopkins, Lothar Kreienbrock, James G. Logan, Hector Lorenzo, Rita de Cassia Carvalho Maia, Juan M. Mancilla-Tapia, Fernando O. Mardones, Leon Mutesa, Sabin Nsanzimana, Cynthia M. Otto, Marília Salgado-Caxito, Florencia de los Santos, Jeine Emanuele Santos da Silva, Esther Schalke, Clara Schoneberg, Anísio Francisco Soares, Friederike Twele, Victor Manuel Vidal-Martínez, Ariel Zapata, Natalia Zimin-Veselkoff, Holger A. Volk. Expert considerations and consensus for using dogs to detect human SARS-CoV-2-infections. Frontiers in Medicine 2022, 9 https://doi.org/10.3389/fmed.2022.1015620
  44. Faezeh Almasi, Wen Dang, Fatemeh Mohammadipanah, Ning Li. Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms. Archives of Pharmacal Research 2022, 45 (12) , 909-937. https://doi.org/10.1007/s12272-022-01420-3
  45. Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lu, Ming Wang, Lin Zhu, Junjian Hu, Tingting Liu, Ke Ma, Meifang Han, Xiaoping Luo. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduction and Targeted Therapy 2022, 7 (1) https://doi.org/10.1038/s41392-022-00907-1
  46. Kobi Snitz, Danielle Honigstein, Reut Weissgross, Aharon Ravia, Eva Mishor, Ofer Perl, Shiri Karagach, Abebe Medhanie, Nir Harel, Sagit Shushan, Yehudah Roth, Behzad Iravani, Artin Arshamian, Gernot Ernst, Masako Okamoto, Cindy Poo, Niccolò Bonacchi, Zachary Mainen, Erminio Monteleone, Caterina Dinnella, Sara Spinelli, Franklin Mariño-Sánchez, Camille Ferdenzi, Monique Smeets, Kazushige Touhara, Moustafa Bensafi, Thomas Hummel, Johan N. Lundström, Noam Sobel. An olfactory self-test effectively screens for COVID-19. Communications Medicine 2022, 2 (1) https://doi.org/10.1038/s43856-022-00095-7
  47. Graciela Cárdenas, María Chávez-Canales, Ana María Espinosa, Antonio Jordán-Ríos, Daniel Anica Malagon, Manlio Fabio Márquez Murillo, Laura Victoria Torres Araujo, Ricardo Leopoldo Barajas Campos, Rosa María Wong-Chew, Luis Esteban Ramirez González, Karent Ibet Cresencio, Enrique García Velázquez, Mariana Rodriguez de la Cerda, Yoana Leyva, Joselin Hernández-Ruiz, María Luisa Hernández-Medel, Mireya León-Hernández, Karen Medina Quero, Anahí Sánchez Monciváis, Sergio Hernández Díaz, Ignacia Rosalia Zeron Martínez, Adriana Martínez-Cuazitl, Iván Noé Martínez Salazar, Eduardo Beltrán Sarmiento, Aldo Figueroa Peña, Patricia Saraí Hernández, Rafel Ignacio Aguilar Reynoso, Daniela Murillo Reyes, Luis Rodrigo del Río Ambriz, Rogelio Antonio Alfaro Bonilla, Jocelyn Cruz, Leonor Huerta, Nora Alma Fierro, Marisela Hernández, Mayra Pérez-Tapia, Gabriela Meneses, Erick Espíndola-Arriaga, Gabriela Rosas, Alberto Chinney, Sergio Rosales Mendoza, Juan Alberto Hernández-Aceves, Jaquelynne Cervantes-Torres, Anai Fuentes Rodríguez, Roxana Olguin Alor, Sandra Ortega Francisco, Evelyn Alvarez Salazar, Hugo Besedovsky, Marta C. Romano, Raúl J. Bobes, Helgi Jung, Gloria Soldevila, Juan López-Alvarenga, Gladis Fragoso, Juan Pedro Laclette, Edda Sciutto. Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients. Trials 2022, 23 (1) https://doi.org/10.1186/s13063-022-06075-5
  48. Vanessa Monroig, Keiko M. Tarquinio. Diabetic ketoacidosis and coronavirus disease 2019-associated mucormycosis: a case report. Journal of Medical Case Reports 2022, 16 (1) https://doi.org/10.1186/s13256-022-03594-2
  49. Feng Chen, Yanting Chen, Yongxiang Wang, Qiongwei Ke, Lili Cui. The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms. Translational Neurodegeneration 2022, 11 (1) https://doi.org/10.1186/s40035-022-00316-y
  50. Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Saad Alhumaid, Zainab Al Alawi, Abbas Al Mutair. COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Human Vaccines & Immunotherapeutics 2022, 18 (5) https://doi.org/10.1080/21645515.2022.2045853
  51. Alef Aragão Carneiro dos Santos, Luiz Eduardo Rodrigues, Amanda Lins Alecrim-Zeza, Liliane de Araújo Ferreira, Caio dos Santos Trettel, Gabriela Mandú Gimenes, Adelson Fernandes da Silva, Celso Pereira Batista Sousa-Filho, Tamires Duarte Afonso Serdan, Adriana Cristina Levada-Pires, Elaine Hatanaka, Fernanda Teixeira Borges, Marcelo Paes de Barros, Maria Fernanda Cury-Boaventura, Gisele Lopes Bertolini, Priscila Cassolla, Gabriel Nasri Marzuca-Nassr, Kaio Fernando Vitzel, Tania Cristina Pithon-Curi, Laureane Nunes Masi, Rui Curi, Renata Gorjao, Sandro Massao Hirabara. Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2. Frontiers in Microbiology 2022, 13 https://doi.org/10.3389/fmicb.2022.1037467
  52. Silvana Papagerakis, Raed Said, Farinaz Ketabat, Razi Mahmood, Meenakshi Pundir, Liubov Lobanova, Greg Guenther, Giuseppe Pannone, Kerry Lavender, Blake R. McAlpin, Alain Moreau, Xiongbiao Chen, Petros Papagerakis. When the clock ticks wrong with COVID‐19. Clinical and Translational Medicine 2022, 12 (11) https://doi.org/10.1002/ctm2.949
  53. Pedro Antônio O.A. Gusmão, José Reinaldo C. Roveda, Ana Sophia M. Leite, Arnaldo S. Leite, Carolina C. Marinho. Changes in olfaction and taste in patients hospitalized for COVID-19 and their relationship to patient evolution during hospitalization. Brazilian Journal of Otorhinolaryngology 2022, 88 , S75-S82. https://doi.org/10.1016/j.bjorl.2021.11.002
  54. Ali Karimian, Mohaddeseh Behjati, Mohammad Karimian. Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2. Archives of Virology 2022, 167 (10) , 1931-1946. https://doi.org/10.1007/s00705-022-05545-0
  55. Mahboobeh Karimi-Galougahi, Ali Safavi Naini, Jahangir Ghorbani, Nasim Raad, Negar Raygani. Emergence and Evolution of Olfactory and Gustatory Symptoms in Patients with COVID-19 in the Outpatient Setting. Indian Journal of Otolaryngology and Head & Neck Surgery 2022, 74 (S2) , 2743-2749. https://doi.org/10.1007/s12070-020-02166-4
  56. Abdolreza Esmaeilzadeh, Reza Elahi, Amir Siahmansouri, Armin Jahani Maleki, Amirhosein Moradi. Endocrine and metabolic complications of COVID-19: lessons learned and future prospects. Journal of Molecular Endocrinology 2022, 69 (3) , R125-R150. https://doi.org/10.1530/JME-22-0036
  57. Harish Kumar, Roquaiya Nishat, Anupama Desai. A review on oral manifestations of COVID-19 disease. Journal of Family Medicine and Primary Care 2022, 11 (10) , 5879-5886. https://doi.org/10.4103/jfmpc.jfmpc_205_22
  58. Songül DEMİR, Bilal SİZER, Enes SIRMA. Management of post-COVID olfactory disorder: Is olfactory training effective on recovery of olfactory mucosal function?. Mucosa 2022, https://doi.org/10.33204/mucosa.1174280
  59. Jayakumar Saikarthik, Ilango Saraswathi, Abdulrahman A. Al-Atram. Does COVID-19 Affect Adult Neurogenesis? A Neurochemical Perspective. 2022https://doi.org/10.5772/intechopen.101179
  60. Kaja Hanna Karakuła, Olga Nowacka, Aleksander Ryczkowski, Ryszard Sitarz, Alicja Forma, Dariusz Juchnowicz. COVID-19-induced psychosis: two case reports and narrative literature review. Current Problems of Psychiatry 2022, 23 (3) , 151-158. https://doi.org/10.2478/cpp-2022-0015
  61. Zhen Xie, Hao Hui, Zhihan Zhao, Wenjin Yu, Rui Wu, Yanzhao Zhu, Yuan Song, Bingqing Cao, Wenzhen Shi, Di Zhao, Yunsong Zhao, Junchao Lv, Qian Yao, Yan Duan, Jingwen Li, Haijun Zhang, Linfu Zhou, Xiaotian Wang, Ye Tian, Gang Zhao. Nervous system manifestations related to COVID-19 and their possible mechanisms. Brain Research Bulletin 2022, 187 , 63-74. https://doi.org/10.1016/j.brainresbull.2022.06.014
  62. Mateus Henrique de Las Casas Lima, Ana Luiza Brusiquesi Cavalcante, Sydney Correia Leão. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review. Brazilian Journal of Otorhinolaryngology 2022, 88 (5) , 794-802. https://doi.org/10.1016/j.bjorl.2021.04.001
  63. Igor Łoniewski, Karolina Skonieczna-Żydecka, Joanna Sołek-Pastuszka, Wojciech Marlicz. Probiotics in the Management of Mental and Gastrointestinal Post-COVID Symptomes. Journal of Clinical Medicine 2022, 11 (17) , 5155. https://doi.org/10.3390/jcm11175155
  64. Geidy E Serrano, Jessica E Walker, Cécilia Tremblay, Ignazio S Piras, Matthew J Huentelman, Christine M Belden, Danielle Goldfarb, David Shprecher, Alireza Atri, Charles H Adler, Holly A Shill, Erika Driver-Dunckley, Shyamal H Mehta, Richard Caselli, Bryan K Woodruff, Chadwick F Haarer, Thomas Ruhlen, Maria Torres, Steve Nguyen, Dasan Schmitt, Steven Z Rapscak, Christian Bime, Joseph L Peters, Ellie Alevritis, Richard A Arce, Michael J Glass, Daisy Vargas, Lucia I Sue, Anthony J Intorcia, Courtney M Nelson, Javon Oliver, Aryck Russell, Katsuko E Suszczewicz, Claryssa I Borja, Madison P Cline, Spencer J Hemmingsen, Sanaria Qiji, Holly M Hobgood, Joseph P Mizgerd, Malaya K Sahoo, Haiyu Zhang, Daniel Solis, Thomas J Montine, Gerald J Berry, Eric M Reiman, Katharina Röltgen, Scott D Boyd, Benjamin A Pinsky, James L Zehnder, Pierre Talbot, Marc Desforges, Michael DeTure, Dennis W Dickson, Thomas G Beach. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19. Journal of Neuropathology & Experimental Neurology 2022, 81 (9) , 666-695. https://doi.org/10.1093/jnen/nlac056
  65. Hiroshi Okuda, Chikako Kunieda, Hirofumi Shibata, Toshimitsu Ohashi, Takenori Ogawa. Bilateral Recurrent Laryngeal Nerve Paralysis Manifesting as Long COVID. Cureus 2022, 324 https://doi.org/10.7759/cureus.27792
  66. Andrea Mazzatenta, Anna Berardi, Gabriele Alessandro Novarria, Giampiero Neri. Unmasking the ‘Asymptomatic’ COVID-19: A Nose Question. Life 2022, 12 (8) , 1248. https://doi.org/10.3390/life12081248
  67. Mária Orendáčová, Eugen Kvašňák. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications. Frontiers in Public Health 2022, 10 https://doi.org/10.3389/fpubh.2022.903568
  68. Noor Allawi, Bashar Abdullah. Immunohistochemical expression of angiotensin‐converting enzyme 2 in superficial and deep maxillofacial tissues: A cross‐sectional study. Health Science Reports 2022, 5 (4) https://doi.org/10.1002/hsr2.737
  69. Sachin C. Sarode, Gargi S. Sarode, Namrata Sengupta, Urmi Ghone. Viral cytopathic effect in maxillary sinus epithelium and SARS-CoV-2: Pitfalls in diagnostic characterization. Journal of Oral Biology and Craniofacial Research 2022, 12 (4) , 437-438. https://doi.org/10.1016/j.jobcr.2022.05.013
  70. Junchao Shi, Zi Li, Jing Zhang, Rongyi Xu, Yungang Lan, Jiyu Guan, Rui Gao, Zhenzhen Wang, Huijun Lu, Baofeng Xu, Kui Zhao, Feng Gao, Wenqi He, . PHEV infection: A promising model of betacoronavirus-associated neurological and olfactory dysfunction. PLOS Pathogens 2022, 18 (6) , e1010667. https://doi.org/10.1371/journal.ppat.1010667
  71. Sareesh Naduvil Narayanan, Pooja Shivappa, Sreeshma Padiyath, Anand Bhaskar, Yan Wa Li, Tarig Hakim Merghani. The Prevalence and Pathophysiology of Chemical Sense Disorder Caused by the Novel Coronavirus. Frontiers in Public Health 2022, 10 https://doi.org/10.3389/fpubh.2022.839182
  72. Siu Wa Tang, Brian E. Leonard, Daiga Maret Helmeste. Long COVID, neuropsychiatric disorders, psychotropics, present and future. Acta Neuropsychiatrica 2022, 34 (3) , 109-126. https://doi.org/10.1017/neu.2022.6
  73. Philippe Voruz, Gilles Allali, Lamyae Benzakour, Anthony Nuber-Champier, Marine Thomasson, Isabele Jacot de Alcântara, Jordan Pierce, Patrice H. Lalive, Karl-Olof Lövblad, Olivia Braillard, Matteo Coen, Jacques Serratrice, Jérôme Pugin, Radek Ptak, Idris Guessous, Basile N. Landis, Frédéric Assal, Julie A. Péron. Long COVID Neuropsychological Deficits after Severe, Moderate, or Mild Infection. Clinical and Translational Neuroscience 2022, 6 (2) , 9. https://doi.org/10.3390/ctn6020009
  74. Julie Fiorentino, Magali Payne, Elisa Cancian, Alexandra Plonka, Louise-Émilie Dumas, David Chirio, Élisa Demonchy, Karine Risso, Florence Askenazy-Gittard, Nicolas Guevara, Laurent Castillo, Philippe Robert, Valeria Manera, Clair Vandersteen, Auriane Gros. Correlations between Persistent Olfactory and Semantic Memory Disorders after SARS-CoV-2 Infection. Brain Sciences 2022, 12 (6) , 714. https://doi.org/10.3390/brainsci12060714
  75. María Luisa Delgado-Losada, Jaime Bouhaben, Claudia Ruiz-Huerta, Marcelle V. Canto, Alice Helena Delgado-Lima. Long-Lasting Olfactory Dysfunction in Hospital Workers Due to COVID-19: Prevalence, Clinical Characteristics, and Most Affected Odorants. International Journal of Environmental Research and Public Health 2022, 19 (9) , 5777. https://doi.org/10.3390/ijerph19095777
  76. Gwenaëlle Douaud, Soojin Lee, Fidel Alfaro-Almagro, Christoph Arthofer, Chaoyue Wang, Paul McCarthy, Frederik Lange, Jesper L. R. Andersson, Ludovica Griffanti, Eugene Duff, Saad Jbabdi, Bernd Taschler, Peter Keating, Anderson M. Winkler, Rory Collins, Paul M. Matthews, Naomi Allen, Karla L. Miller, Thomas E. Nichols, Stephen M. Smith. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 2022, 604 (7907) , 697-707. https://doi.org/10.1038/s41586-022-04569-5
  77. Carlotta Pipolo, Daniele Bottai, Emanuela Fuccillo, Eleonora Aronica, Fabio Bruschi, Antonio Mario Bulfamante, Luca Castellani, Maria Paola Canevini, Davide Chiumello, Sergio Ferrari, Carla Martinelli, Stefano Muttini, Alberto Priori, Alberto Maria Saibene, Chiara Spoldi, Delfina Tosi, Gianluigi Zanusso, Gaetano Pietro Bulfamante, Giovanni Felisati, . Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients. PLOS ONE 2022, 17 (4) , e0266740. https://doi.org/10.1371/journal.pone.0266740
  78. Abdulrahman K. Ahmed, Reem Sayad, Islam A. Mahmoud, Aya M. Abd EL-Monem, Salma H. Badry, Islam H. Ibrahim, Mahmoud HR Hafez, Mohamed A. El-Mokhtar, Ibrahim M. Sayed. “Anosmia” the mysterious collateral damage of COVID-19. Journal of NeuroVirology 2022, 28 (2) , 189-200. https://doi.org/10.1007/s13365-022-01060-9
  79. Daniel Wu, Victoria Y. Wang, Ya-Hui Chen, Chih-Hung Ku, Pa-Chun Wang. The prevalence of olfactory and gustatory dysfunction in covid-19 - A systematic review. Auris Nasus Larynx 2022, 49 (2) , 165-175. https://doi.org/10.1016/j.anl.2021.07.007
  80. Rajesh Kumar, Seetha Harilal, Sabitha M., Leena K. Pappachan, Roshni P.R., Bijo Mathew. Current Perspective of COVID-19 on Neurology: A Mechanistic Insight. Combinatorial Chemistry & High Throughput Screening 2022, 25 (5) , 763-767. https://doi.org/10.2174/1386207324666210805121828
  81. Laura Ziuzia-Januszewska, Marcin Januszewski. Pathogenesis of Olfactory Disorders in COVID-19. Brain Sciences 2022, 12 (4) , 449. https://doi.org/10.3390/brainsci12040449
  82. Eric A. Liu, Tomas Salazar, Elisa Chiu, Talya K. Fleming, Leslie Bagay, David P. Brown, Sara J. Cuccurullo. Focal Peripheral Neuropathies Observed in Patients Diagnosed With COVID-19. American Journal of Physical Medicine & Rehabilitation 2022, 101 (2) , 164-169. https://doi.org/10.1097/PHM.0000000000001924
  83. Büşra Ünlü, Rahime Simsek, Selinay Başak Erdemli Köse, Anıl Yirün, Pinar Erkekoglu. Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs Against COVID-19. Mini-Reviews in Medicinal Chemistry 2022, 22 (2) , 213-231. https://doi.org/10.2174/1389557521666210629100630
  84. Francesco Cavallieri, Johann Sellner, Marialuisa Zedde, Elena Moro. Neurologic complications of coronavirus and other respiratory viral infections. 2022, 331-358. https://doi.org/10.1016/B978-0-323-91532-8.00004-5
  85. Jasmin Dionne Haslbauer, Anna Stalder, Carl Zinner, Stefano Bassetti, Kirsten Diana Mertz, Philip Went, Matthias Matter, Alexandar Tzankov. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. Pathobiology 2022, 89 (3) , 166-177. https://doi.org/10.1159/000520221
  86. Lisa Hentsch, Sara Cocetta, Gilles Allali, Isabelle Santana, Rowena Eason, Emily Adam, Jean-Paul Janssens. Atemnot und COVID-19: Ein Aufruf zu mehr Forschung. Kompass Pneumologie 2022, 10 (1) , 6-14. https://doi.org/10.1159/000521460
  87. Lisa Hentsch, Sara Cocetta, Gilles Allali, Isabelle Santana, Rowena Eason, Emily Adam, Jean-Paul Janssens. Dificultad respiratoria y COVID-19: Un llamado a la investigación. Kompass Neumología 2022, 4 (1) , 21-28. https://doi.org/10.1159/000521663
  88. Glória de Moraes Marchiori, Braulio Henrique Magnani Branco, Daiane de Almeida Ciquinato, Aline Diniz Gehren, Gabriel Henrique Carvalho, Jayson Júnior Mesti, Luciana Lozza de Moraes Marchiori. Anosmia and ageusia in people after COVID-19: an analysis between the type and length of hospital stay. Revista CEFAC 2022, 24 (2) https://doi.org/10.1590/1982-0216/20222429322
  89. Glória de Moraes Marchiori, Braulio Henrique Magnani Branco, Daiane de Almeida Ciquinato, Aline Diniz Gehren, Gabriel Henrique Carvalho, Jayson Júnior Mesti, Luciana Lozza de Moraes Marchiori. Anosmia e ageusia em pessoas após a COVID-19: análise entre tipo e tempo de hospitalização. Revista CEFAC 2022, 24 (2) https://doi.org/10.1590/1982-0216/20222429322s
  90. Siti Masliana Siregar, Ratih Yulistika Utami. The Effect of Nasal Irrigation on COVID-19 Patient’s Mild Symptoms of Respiratory Tract. Open Access Macedonian Journal of Medical Sciences 2022, 10 (B) , 1497-1501. https://doi.org/10.3889/oamjms.2022.9013
  91. Mayada Elgendy, Hossam Magdy Balaha, Mohamed Shehata, Ahmed Alksas, Mahitab Ghoneim, Fatma Sherif, Ali Mahmoud, Ahmed Elgarayhi, Fatma Taher, Mohammed Sallah, Mohammed Ghazal, Ayman El-Baz. Role of Imaging and AI in the Evaluation of COVID-19 Infection: A Comprehensive Survey. Frontiers in Bioscience-Landmark 2022, 27 (9) https://doi.org/10.31083/j.fbl2709276
  92. Sapana Sharma, Harsha Jagadeesh, Ambrish Saxena, Harshini Chakravarthy, Vasudharani Devanathan. Central nervous system as a target of novel coronavirus infections: Potential routes of entry and pathogenic mechanisms. Journal of Biosciences 2021, 46 (4) https://doi.org/10.1007/s12038-021-00232-9
  93. Dandan Wan, Tingfu Du, Weiqi Hong, Li Chen, Haiying Que, Shuaiyao Lu, Xiaozhong Peng. Neurological complications and infection mechanism of SARS-CoV-2. Signal Transduction and Targeted Therapy 2021, 6 (1) https://doi.org/10.1038/s41392-021-00818-7
  94. Ana M. B. Menezes, Cesar G. Victora, Fernando P. Hartwig, Mariângela F. Silveira, Bernardo L. Horta, Aluísio J. D. Barros, Marilia A. Mesenburg, Fernando C. Wehrmeister, Lúcia C. Pellanda, Odir A. Dellagostin, Cláudio J. Struchiner, Marcelo N. Burattini, Fernando C. Barros, Pedro C. Hallal. High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2. Scientific Reports 2021, 11 (1) https://doi.org/10.1038/s41598-021-92775-y
  95. Molly Brady, Conor McQuaid, Alexander Solorzano, Angelique Johnson, Abigail Combs, Chethana Venkatraman, Akib Rahman, Hannah Leyva, Wing-Chi Edmund Kwok, Ronald W. Wood, Rashid Deane. Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2. Communications Biology 2021, 4 (1) https://doi.org/10.1038/s42003-021-02856-x
  96. Eli Ben‐Chetrit, Ami Ben‐Ya'acov, Ahmad Quitina, Ohad Atia, Eran Regev, Eyal Shteyer, Rizan Nashef. Anosmia and dysgeusia amongst COVID‐19 patients are associated with low levels of serum glucagon‐like peptide 1. International Journal of Clinical Practice 2021, 75 (12) https://doi.org/10.1111/ijcp.14996
  97. Silvia Torices, Rosalba Cabrera, Michael Stangis, Oandy Naranjo, Nikolai Fattakhov, Timea Teglas, Daniel Adesse, Michal Toborek. Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection. Journal of Neuroinflammation 2021, 18 (1) https://doi.org/10.1186/s12974-021-02210-2
  98. Conor McQuaid, Molly Brady, Rashid Deane. SARS-CoV-2: is there neuroinvasion?. Fluids and Barriers of the CNS 2021, 18 (1) https://doi.org/10.1186/s12987-021-00267-y
  99. Ummehan Ermis, Marcus Immanuel Rust, Julia Bungenberg, Ana Costa, Michael Dreher, Paul Balfanz, Gernot Marx, Martin Wiesmann, Kathrin Reetz, Simone C. Tauber, Jörg B. Schulz. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients. Neurological Research and Practice 2021, 3 (1) https://doi.org/10.1186/s42466-021-00116-1
  100. Rafal Butowt, Christopher S. von Bartheld. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. The Neuroscientist 2021, 27 (6) , 582-603. https://doi.org/10.1177/1073858420956905
Load more citations

ACS Chemical Neuroscience

Cite this: ACS Chem. Neurosci. 2020, 11, 9, 1200–1203
Click to copy citationCitation copied!
https://doi.org/10.1021/acschemneuro.0c00172
Published April 13, 2020
Copyright © 2020 American Chemical Society

Article Views

20k

Altmetric

-

Citations

Learn about these metrics

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

  • Figure 1

    Figure 1. Diagram of human nasal cavity with respiratory and olfactory epithelium areas indicated in blue and yellow, respectively.

    Figure 2

    Figure 2. Basic organization of the olfactory epithelium (OE). Olfactory neurons continuously regenerate through human life and therefore are at different stages of differentiation. Some non-neuronal cells are shown, e.g., progenitors, sustentacular cells, and olfactory ensheathing cells.

  • References


    This article references 10 other publications.

    1. 1
      Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., and Ren, L. (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 11, 1620,  DOI: 10.1038/s41467-020-15562-9
    2. 2
      Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kruger, N., Herrler, T., Erichsen, S., Schiergens, E. S., Herrler, G., Wu, N.-H., Nitsche, A., Muller, M. A., Drosten, C., and Pohlmann, S. (2020) SARS-CoV-2 cell entry depends on ACE2 and TRMPSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 110,  DOI: 10.1016/j.cell.2020.02.052
    3. 3
      Ruiz Garcia, S., Deprez, M., Lebrigand, K., Cavard, A., Paquet, A., Arguel, M.-J., and Zaragosi, L.-E. (2019) Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development 146, dev.177428,  DOI: 10.1242/dev.177428
    4. 4
      Olender, T., Keydar, I., Pinto, J. M., Tatarskyy, P., Alkelai, A., Chien, M.-S., Fishilevich, S., Restrepo, D., Matsunami, H., Gilad, Y., and Lancet, D. (2016) The human olfactory transcriptome. BMC Genomics 17, 619,  DOI: 10.1186/s12864-016-2960-3
    5. 5
      Kangeswaran, N., Demond, M., and Nagel, M. (2015) Deep sequencing of the murine olfactory receptor transcriptome. PLoS One 10 (1), e0113170,  DOI: 10.1371/journal.pone.0113170
    6. 6
      Saraiva, L. R., Ibarra-Soria, X., Khan, M., Omura, M., Scialdone, A., Mombaerts, P., Marioni, J. C., and Logan, D. W. (2015) Hierarchical deconstruction of mouse olfactory sensory neurons: from whole mucosa to single-cell RNA-seq. Sci. Rep. 5, 18178,  DOI: 10.1038/srep18178
    7. 7
      Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., and Perlman, S. (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol 82 (5), 726475,  DOI: 10.1128/JVI.00737-08
    8. 8
      Harberts, E., Yao, K., Wohler, J. E., Maric, D., Ohayon, J., Henkin, R., and Jacobson, S. (2011) Human herpesvirus-6 entry into CNS through the olfactory pathway. Proc. Natl. Acad. Sci. U. S. A. 108 (33), 13734,  DOI: 10.1073/pnas.1105143108
    9. 9
      Baig, A. M., Khaleeq, A., Ali, U., and Syeda, H. (2020) Evidence of the COVID-19 virus targeting the CNS: host-virus interactions and proposed neurotropic mechanisms. ACS Chem. Neurosci. 11, 995,  DOI: 10.1021/acschemneuro.0c00122
    10. 10
      Sepahi, A., Kraus, A., Casadei, E., Johnston, C. A., Galindo-Villegas, J., Kelly, C., Garcia-Moreno, D., Munoz, P., Mulero, V., Huertas, M., and Salinas, I. (2019) Olfactory sensory neurons mediate ultrarapid antiviral immune responses in a TrkA-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 116 (25), 1242836,  DOI: 10.1073/pnas.1900083116